This document is an excerpt from the EUR-Lex website
Document 22019D0739
Decision of the EEA Joint Committee No 132/2017 of 7 July 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/739]
Decision of the EEA Joint Committee No 132/2017 of 7 July 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/739]
Decision of the EEA Joint Committee No 132/2017 of 7 July 2017 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/739]
OJ L 128, 16.5.2019, p. 24–25
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
In force
|
16.5.2019 |
EN |
Official Journal of the European Union |
L 128/24 |
DECISION OF THE EEA JOINT COMMITTEE
No 132/2017
of 7 July 2017
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2019/739]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Regulation (EU) 2016/1826 of 14 October 2016 concerning the non-approval of the active substance tricyclazole, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Regulation (EU) 2016/2016 of 17 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, benzoic acid, flazasulfuron, mecoprop-P, mepanipyrim, mesosulfuron, propineb, propoxycarbazon, propyzamide, propiconazole, Pseudomonas chlororaphis Strain: MA 342, pyraclostrobin, quinoxyfen, thiacloprid, thiram, ziram, zoxamide (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Regulation (EU) 2016/2035 of 21 November 2016 amending Implementing Regulation (EU) No 540/2011 as regards the approval periods of the active substances fipronil and maneb (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:
|
1. |
The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):
|
|
2. |
The following point is inserted after point 13zzzzzzr (Commission Implementing Regulation (EU) 2016/1978):
|
Article 2
The texts of Implementing Regulations (EU) 2016/1826, (EU) 2016/2016 and (EU) 2016/2035 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 8 July 2017, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 7 July 2017.
For the EEA Joint Committee
The President
Sabine MONAUNI
(1) OJ L 279, 15.10.2016, p. 88.
(2) OJ L 312, 18.11.2016, p. 21.
(3) OJ L 314, 22.11.2016, p. 7.
(*1) No constitutional requirements indicated.